Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT04391660
Eligibility Criteria:
Inclusion Criteria:
* Adult patient (≥18 years old) requiring hospitalization in participating services
* Having an indication for the placement of a peripheral venous catheter for an expected duration of at least 48 hours
* Free subject, without guardianship or curatorship or subordination
* A person affiliated to or benefiting from a social security scheme.
* Having given free and informed consent
Exclusion Criteria:
* Hypersensitivity to any of the constituents of Dakin® and/or Cooper® modified alcohol;
* History of epilepsy,
* Placement of a peripheral venous catheter in the emergency room that does not allow the usual rules of hygiene to be respected;
* Difficult vascular access foreseeable (drug addict, obese, non-visible veins...);
* Participation in another research protocol reducing the risk of catheter-related infection;
* Patient having received an antibiotic treatment in the 15 days prior to inclusion in the study;
* Patient who has already participated in the study;
* Subjects not affiliated with a Social Security system.
* Subjects benefiting from enhanced protection, namely persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection (guardianship and trusteeship) and finally patients in emergency situations.
* Pregnant or breastfeeding women, women of child-bearing age who do not have effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy...).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04391660
Study Brief:
Protocol Section:
NCT04391660